Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
microsatellite instability-high cancer
Pharma
Merck's Keytruda doubles time to colorectal cancer progression
The results are out, and they’re practice-changing: Keytruda can double the time to progression in patients with certain types of colorectal cancer.
Carly Helfand
May 28, 2020 5:00pm
Merck looks for lead on BMS with Keytruda colorectal cancer win
Apr 2, 2020 11:14am
Bristol-Myers Squibb's Opdivo nabs MSI-H colorectal cancer nod
Aug 1, 2017 9:26am
Merck's Keytruda wins first-ever FDA nod in MSI-H cancer
May 23, 2017 4:11pm
